Class action lawsuits
Faruqi & Faruqi, a leading national securities law firm, is investigating potential claims against Centene Corporation and reminds investors of the September 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action. The firm is looking into allegations that Centene provided false and misleading
Class action lawsuits
Rosen Law Firm announces the filing of a class action lawsuit against Fiserv, Inc. on behalf of investors who purchased the company's common stock between July 24, 2024, and July 22, 2025. The lawsuit alleges that Fiserv made false and misleading statements about its Clover platform, concealing a
Class action lawsuits
A shareholder has initiated a securities class action lawsuit on behalf of investors who purchased Fiserv common stock between July 24, 2024, and July 22, 2025. The lawsuit, filed against Fiserv, alleges that the company made misrepresentations about its growth numbers through the compelled migration of legacy customers from its
Class action lawsuits
Pursuers or acquirers of Fiserv, Inc. common stock between July 24, 2024, and July 22, 2025, have until September 22, 2025, to seek appointment as lead plaintiff of the Fiserv class action lawsuit. The lawsuit charges Fiserv and its top executives with violating the Securities Exchange Act of 1934 by
Class action lawsuits
Rocket Pharmaceuticals, a biotechnology company developing gene therapies for rare diseases, is at the center of a shareholder class action lawsuit following allegations that it misled investors about the safety and progress of its critical RP-A501 gene therapy trial for Danon disease. The lawsuit, filed in response to the FDA&
Class action lawsuits
Faruqi & Faruqi, a leading national securities law firm, is investigating potential claims against Alto Neuroscience, Inc. ("Alto" or the "Company") and reminds investors of the September 19, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been
Class action lawsuits
Rosen Law Firm, a global investor rights law firm, has announced the filing of a class action lawsuit on behalf of purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO) in connection with the company's initial public offering (IPO) conducted on February 2, 2024, and subsequent securities
Class action lawsuits
Attorney Bronstein, Gewirtz & Grossman, LLC has notified investors that a class action lawsuit has been filed against Alto Neuroscience, Inc. and certain of its officers. The lawsuit seeks to recover damages for alleged violations of federal securities laws on behalf of investors who purchased or acquired Alto common stock
Class action lawsuits
The Gross Law Firm has issued a notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO), urging those who purchased shares of the company during the class period to contact the firm regarding possible lead plaintiff appointment. The allegations against Alto Neuroscience include the company issuing false and misleading statements
Class action lawsuits
3D Systems Corporation, a leading provider of 3D printing and digital manufacturing solutions, has been sued in a class action lawsuit by investors who purchased or acquired the company's securities between August 13, 2024, and May 12, 2025. The lawsuit, filed in the United States District Court for
Class action lawsuits
A class action lawsuit has been filed against 3D Systems Corporation for alleged violations of securities laws. The lawsuit claims that the company made false and misleading statements to the market, minimizing the effect of declining customer spending on its operations and concealing the impact of revised milestone requirements on
Class action lawsuits
A class action securities lawsuit has been filed against 3D Systems Corporation, alleging that the company made false statements and concealed the true impact of weakened customer spending on its business. The lawsuit claims that the company understated its financial struggles and overstated its resilience in the face of challenging
